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ABSTRACT 
Simple and accurate UV spectrophotometric methods by Zero, First and Second order derivative method  have been develop ed and validated 
for the estimation of Olopatadine hydrochloride in bulk and its pharmaceutical dosage form. The standard and sample solutions of Olopatadine 
hydrochloride were prepared in methanol and water. Olopatadine hydrochloride was estimated at 299, 289 and 267 nm for the  derivative UV-
spectrophotometric method. Beer’s law was obeyed in the concentration range of 20 to 120 μg / mL with coefficient of correlat ion value 0.9996, 
0.999 and 0.999 for Zero, First and Second order derivative method. These methods were tested and validated for various parameters 
according to ICH and USP guidelines. The precision expressed as relative standard deviation were of less than 2 for the above three methods 
respectively. The proposed methods were successfully applied for the determination of Olopatadine hydrochloride in pharmaceutical dosage 
form. Results of the analysis were validated statistically and were found to be satisfactory. The proposed methods are simple, easy to apply, 
low-cost and require relatively inexpensive instruments. 
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INTRODUCTION 
The chemically Olopatadine hydrochloride is {(11Z)-11-[3-
(di-methyl-amino) propylideine]-6, 11-dihydrodibenzo [b, e] 
oxepin-2-yl} acetic acid, hydrochloride. (Figure1) 
corresponding to the molecular formula (C21H23 NO3.HCl).  
Olopatadine  HCl  has a relative molecular mass of  373.873 
g/mole. [1 ,2, 3, 4] 
 
Figure 1. Chemical structure of  Olopatadine 
Hydrochloride 
Olopatadine HCl is a selective histamine H1 receptor-
antagonist activity and inhibits the release of histamine from 
mast cell. It is used to treat itching associated with allergic 
conjunctivitis. Its principal effects are inhibition of H1 
receptors.  They act on the bronchi, capillaries, and other 
smooth muscles.[3, 1] 
The literature survey reveals that numerous methods for 
determinations of Olopatadine HCl  in single  in 
pharmaceutical dosage forms,[4,5,6] spectrophotometric 
methods in combination with other drugs [7,8], HPTLC 
[9,10], stability indicating spectrophotometric [11,12], HPLC 
methods in combination with other drug including HPLC 
[13,14] and UPLC method in bulk and pharmaceutical 
dosage form[15]. In this study we described very simple, 
sensitive, novel spectrophotometric methods. These 
methods show very simple, precise, cost effective and 
accurate approach for the analysis of Olopatadine HCl. For 
these methods there is no need of sophisticated instruments, 
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expensive solvents or a large number of samples. 
MATERIALS AND METHODS  
Pure sample of Olopatadine HCl was kindly supplied as a gift 
sample by Aurobindo Pharmaceuticals (Hyderabad, 
Maharashtra) India. All solvents and chemicals were of 
analytical grade. Marketed Tablet dosage form used in this 
research work was WINOLAP 5mg (SUN PHARMA ) acquired 
from local market. 
Instruments 
Spectrophotometric measurements were carried out on 
Shimadzu UV 1800 double beam spectrophotometer. 
Infrared spectroscopic study was done on FTIR (Bruker, 
Japan) . 
 
Preparation of standard stock solution 
Standard stock solution of Olopatadine Hydrochloride was 
prepared by accurately weighing 100 mg of Olopatadine 
Hydrochloride to 100 ml volumetric flask with 10 mL of 
methanol. The drug was sonicated and volume was made up 
to mark with water to get the concentration of 1000 μg/ml. 
Selection of analytical wavelength for zero order 
derivative method 
0.1mL of the standard stock was pipette out and transfers to 
10 ml volumetric flask and volume was made up to mark 
with water. The solution was than scanned in UV range 
between 200-400nm UV-VIS Spectrophotometer, 
Shimadzu, Japan to determine the absorption maxima of the 
drug against blank as water. The absorption maxima were 
found to be 299 nm and it is shown in Figure 2. 
 
 
Figure 2. Zero Order Derivative Spectra of Olopatadine HCl 
 
Selection of analytical wavelength for First order 
derivative method 
The 0.1 mL of the standard stock was pipette out and 
transfers to 10 ml volumetric flask and volume was made up to 
mark with water. The solution was scanned in the 
wavelength range of 200 - 400 nm using UV 
spectrophotometer. The conversion of normal spectrum into 
first order derivative spectrum was done. The spectrum 
shows the sharp peak and maximum absorbance at 289 nm. 
The λmax 289 nm was selected for the first order derivative 
analysis and it is shown in Figure 3. 
 
 
Figure 3. First Order Derivative Spectra of Olopatadine HCl 
Selection of analytical wavelength for Second order 
derivative method 
The 0.1 mL of the standard stock was pipette out and 
transfers to 10 ml volumetric flask and volume was made up to 
mark with water. The solution was scanned in the 
wavelength range of 200 - 400 nm using UV 
spectrophotometer. The conversion of normal spectrum into 
first order derivative spectrum was done. The spectrum 
shows the sharp peak and maximum absorbance at 267 nm. 
The λmax 267 nm was selected for the first order derivative 
analysis and it is shown in Figure 4. 
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Figure 4. Second Order Derivative Spectra of Olopatadine HCl 
 
Preparation of calibration curve for Zero, First and 
Second order derivative methods 
Aliquots portion  0.2, 0.4, 0.6, 0.8, 1.0, 1.2  mL was pipetted out 
from the standard stock solution and transferred to series of 
10 mL volumetric flask and volume was made with water to 
get the concentration range from 20-120μg/ml. The 
absorbance was measured three times for each concentration. 
Absorbance of each solution was measured against water as 
blank at 299 nm and 289nm and  267 nm for zero order,  first 
order and Second order  methods respectively. 
  Analysis of tablet formulation 
Twenty tablets were weighed and finely powdered. Equivalent 
to 10 mg of Olopatadine HCl was weighed and transferred to a 
100 ml volumetric flask containing with specific 10 mL  of  
methanol and sonicated for 20 minutes. The solution was 
filtered through 0.45μm Whatmann filter and volume was 
made up to mark with water and mixed to get 100μg/ml. An 
aliquot of tablet stock solution 3 ml was transferred to 10 ml 
volumetric flask and volume was made up to mark with water 
to get concentration of 10μg/ml of Olopatadine HCl. 
Recovery study of tablet formulation is shown in Table 1.
 
Table 1. Result for tablet analysis (Label Claim) 
Parameters Zero Order First Order Second Order 
Tablet Winolap (5 mg) Winolap (5 mg) Winolap (5 mg) 
Mean*(n=6) 101.35 100.28 98.92 
SD 0.37 1.06 0.54 
% RSD 0.36 0.06 0.55 
 
 
RESULTS AND DISCUSSION [16,17,18] 
Method validation 
The method of analysis was validated as per the 
recommendations of ICH and USP for the parameters like 
accuracy, linearity, precision, detection limit, quantitation 
limit, ruggeddness and  robustness. 
 
           
 SD: Standard Deviation 
%RSD: Relative standard deviation N: Number of data values 
in data set X: Each of values of the       data set 
Linearity 
The linearity of proposed derivative methods was evaluated 
by plotting the absorbance against concentrations of 
standard drug solutions. Stock solutions was consequently 
diluted with water to get 20, 40, 60, 80, 100, 120 μg/mL. The 
λmax for first and second  order derivative was obtained by 
converting the normal spectrum of zero order spectrum to 
first order spectrum and second order spectrum. The 
correlation coefficient was found to be 0.9996, 0.999 and 
0.999 for zero order, first order and Second order derivative 
method. The result for calibration curve of zero, first and  
second order derivative spectrophotometric method shown 
in Figure 5, 6, 7. 
Result for Linearity: 
Preparation of calibration curve  
 
Figure 5: Calibration curve for Olopatadine HCl by Zero 
Order spectrophotometric method 
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Figure 6 : Calibration curve for Olopatadine HCl by First 
order spectrophotometric method 
 
Figure 7: Calibration curve for Olopatadine HCl by 
Second order derivative spectrophotometric method
 
Precision 
The Precision study of analytical method validation express 
the closeness of agreement (degree of scatter) between a 
series of measurements obtained from  multiple sampling of 
day precision of  proposed  methods  was evaluated by 
analysing the three different independent concentrations i.e. 
40, 60, 80 μg/ml in triplicate. These concentrations were 
evaluated for three consecutive days and the results are 
given in Table 2, 3 and  4  for zero order, first  order and 
second order derivative spectrophotometric method.
 
 
Table 2: Result for Precision Study for Intra-Day and Inter- Day (Zero Order).
 Conc. Intra-Day Precision Inter-Day Precision 
Statistical Analysis (μg/ml) 
Amount Found 
(n=3) 
%RSD 
Amount Found 
(n=3) 
%RSD 
Statistically the terms like SD and %RSD 
calculated  in presented study. The standard 
values are mentioned In ± SD 
40 99.83±0.70 0.71 99.02±0.93 0.94 
 60 101.25±0.74 0.73 100.64±0.61 0.60 
 80 101.34±0.24 0.23 101.02±0.52 0.51 
Table 3 :Result  for Precision Study for Intra-Day and Inter-Day (First Order) 
Conc Intra-Day Precision Inter-Day Precision 
(μg/ml) Amount Found (n=3)  %RSD Amount Found (n=3)  %RSD 
40 101.99±0.0006 0.23 100.87±0.0020 0.81 
60 102.09±0.0034 0.95 100.92±0.0034 0.94 
80 101.11±0.0037 0.81 100.87±0.0015 0.33 
 
Table 4:  Result for Precision Study for Intra-Day and Inter-Day (Second  Order) 
Conc Intra-Day Precision Inter-Day Precision 
(μg/ml) Amount Found (n=3) %RSD Amount Found (n=3)  %RSD 
40 101.64±0.0006 0.18 100.95±0.0025 0.79 
60 99.53±0.0005 0.13 100.36±0.0015 0.33 
80 99.04±0.0061 1.01 99.72±0.0041 0.69 
 
Accuracy 
The accuracy of an analytical procedure expresses the 
results obtained by that method to the true value. The 
accuracy of the developed method was determined on the 
basis of recovery studies. The recovery tests were 
performed by adding known quantity of pure standard drug 
into the solution of tablet powder. The sample was then 
spiked with standard at levels 50%, 100% and 150% of tests 
concentrations. The resulting spiked sample solutions were 
analysed in triplicate. The result for accuracy shown in Table 
5. 
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Table 5: Result for accuracy (Recovery) Study 
Zero Order First Order Second  Order 
Level of addition % recovery (n=3) Level of addition % recovery (n=3) Level of addition % recovery (n=3) 
50% 99.81±0.0026 50% 100.180 50% 100.82±0.0026 
100% 99.08±0.0011 100% 99.993 100% 99.33±0.0011 
150% 99.82±0.0012 150% 99.049 150% 101.17±0.0015 
 
Limit of Detection (LOD) Limit of Quantitation (LOQ) 
The LOD and LOQ were evaluated from the data obtained 
from calibration curve. The LOD and LOQ for zero order 
derivative method was found to be  0.530μg/ml and 
1.607μg/ml respectively, for first order derivative was found 
to be 0.863μg/ml and 2.877μg/ml and for second order 
derivative method was found to be  0.616μg/ml and 
2.052μg/ml respectively. 
 Robustness 
Robustness of an analytical procedure is the measure of its 
capacity to remain unaffected by small but deliberate 
variations in method parameters. The robustness study of 
proposed method was evaluated by changing parameters like 
wavelength. In the proposed method the robustness study 
was studied by changing the wavelength (297 and 301) for 
zero order and (287 and 291) for first order derivative 
methods and (265 and 269) for Second Order derivative. The 
robustness testing for both the methods are given in Table 6, 
which indicates that, no significant difference was observed 
in results. Thus, it's demonstrated that the methods are 
robust.
 
 
Table 6. Result for Robustness Study 
Parameters Zero Order First Order Second Order 
 Wavelength 
297 nm 
Wavelength 
301 nm 
Wavelength 
287  nm 
Wavelength 
291 nm 
Wavelength 
265  nm 
Wavelength 
269  nm 
Conc. (μg/mL)                        40 μg/mL 40 μg/mL 30 μg/mL 30 μg/mL 60 μg/mL 60 μg/mL 
Mean (n=5) 0.280 0.277 0.158 0.186 0.532 0.614 
±SD 0.0016 0.0016 0.0016 0.0023 0.0049 0.0039 
% RSD 0.5725 0.5787 1.012 1.2259 0.9265 0.6406 
 
Ruggedness 
Ruggedness is the degree of reproducibility of the results 
obtained under a variety of conditions. Ruggedness study 
was performed to examine effect of non-procedure related 
factors such as instruments and analyst. Ruggedness study of 
Olopatadine HCl was carried out by using two different 
analyst under the similar operational and environmental 
conditions. The % RSD for zero order, first order and second 
order derivative for change in analyst was found in limit (< 
2%) which is shown in Table 7.  
 
Table 7. Result for Ruggedness Study 
Parameters Zero Order First Order Second  Order 
 Analyst I Analyst II Analyst I Analyst II Analyst I Analyst II 
Conc. (μg/mL) 30 (μg/mL) 30 (μg/mL) 20 (μg/mL)    20 (μg/mL) 80 (μg/mL) 80 (μg/mL) 
Mean(n=5) 0.213 0.275 0.121 0.119 0.531 0.576 
±SD 0.000752 0.00233 0.0008 0.0016 0.006 0.004 
% RSD 0.3537 0.8491 0.6213 1.344 1.089 0.742 
 
Specificity 
Specificity study is the ability to asses unequivocally the analyte in 
the presence of component which may be expected to be present. 
For the specificity study of proposed method the sample may be 
spiked with excipients or possible interfering components. 
Results of specificity study were found in analytical limits shown 
in Table 8. 
 
Table 8. Result for Speciﬁcity Study 
Level of 
Addition 
Std. drug 
conc. 
Exipients 
Conc. 
Total conc. Zero Order First Order Second Order 
(μg/mL) (μg/mL) (μg/mL) Abs. % RSD Abs. %RSD Abs. %RSD 
50% 20 40 60 0.150 0.38 0.145 0.39 0.177 0.33 
100% 40 40 80 0.279 0.35 0.247 0.40 0.312 0.67 
150% 60 40 100 0.429 0.23 0.351 0.59 0.461 0.13 
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In proposed method % RSD was found to be less than 2%. The 
method is highly sensitive and entirely suitable for routine 
analysis of Olopatadine HCl in bulk and solid dosage forms. 
CONCLUSION 
The developed analytical method for Olopatadine HCl by 
zero order derivative, first order derivative and second 
order derivative spectroscopic methods was found to be 
linear, specific, rapid and precise. The solvent used in 
proposed methods is methanolic water is an economical and 
cheap, which indicates that the proposed methods are 
economic and cost effective. The %RSD for all validation 
parameters studied. 
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